Tuesday, June 30, 2015 5:19:09 PM
Whilst we have raised the previosly estimated $2million required to obtain US Food and Drug Administration approval
of the patented process for humans and to make the product available to our targeted markets our due diligence has
been successfully completed and contracts now signed subject only to the remittance and clearance of funds.The
new loan investment in the Company will allow trials to recommence. The delay in receiving the new funding, due to
circumstances beyond our control or influence, has prevented us from pursuing the FDA approval, appointing our
preferred investor relations and public relations consultants and commissioning the new website.
http://www.otcmarkets.com/financialReportViewer?symbol=TCEL&id=138904
You should not make any trades or decisions based upon anything said or written by posts on this board with regard to investments without consulting a professional financial planner/adviser..
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM